Investment Rating - The report assigns an "Accumulate" rating to the company [6]. Core Insights - The company is a leading player in the African hygiene products market and has officially listed on the Hong Kong Stock Exchange. The emerging market for hygiene products shows high growth potential, and the company is expected to maintain strong performance [2][11]. Financial Summary - Total revenue is projected to grow from $411.37 million in 2023 to $669.08 million by 2027, reflecting a compound annual growth rate (CAGR) of 28.6% in 2023 and a gradual decline to 12.9% by 2027 [4]. - Net profit is expected to increase significantly from $64.68 million in 2023 to $147.41 million in 2027, with a remarkable growth of 251.7% in 2023 [4]. - The company’s price-to-earnings (PE) ratio is forecasted to be 3.32 in 2023, dropping to 16.22 by 2027, indicating a potential increase in valuation as earnings grow [4]. Industry Overview - The African hygiene products market is expected to grow at a CAGR of 7.9% from 2024 to 2029, positioning it as the fastest-growing market globally [11]. - The market is highly concentrated, with the company holding a market share of 17.2% in baby diapers and 11.9% in sanitary napkins by revenue, while leading in sales volume with 20.3% and 15.6% respectively [11][19]. Competitive Advantages - The company has a comprehensive brand portfolio covering various price segments, with high brand recognition and repurchase rates in the baby diaper and sanitary napkin categories [11][19]. - It has established a robust distribution network across over 30 countries in Africa, reaching more than 80% of the local population [11][19]. - The company achieves 100% local production in Africa, which enhances its supply chain efficiency and cost-effectiveness [11][19]. Future Outlook - Revenue growth is anticipated to be driven by increasing market share in emerging markets and improved production capacity utilization [11][19]. - Profit margins are expected to benefit from brand upgrades and structural optimization, offsetting potential adverse fluctuations in raw material prices [11][19]. Earnings Forecast - The company’s earnings per share (EPS) are projected to be $0.17, $0.21, and $0.24 for the years 2025, 2026, and 2027 respectively [11][15]. - Revenue from key products such as baby diapers, pull-ups, sanitary napkins, and wet wipes is expected to grow significantly, with specific growth rates of 10.1%, 37.2%, 24.8%, and 37.7% respectively from 2025 to 2027 [15][16]. Valuation Analysis - The report suggests a target price of $5.19 per share (equivalent to 40.36 HKD), based on a PE ratio of 30x for 2025, reflecting the company's strong growth potential in overseas markets [11][17].

经营质量持续改善，AI 业务落地迅速 汉得信息(300170) 汉得信息跟踪报告 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 杨林(分析师) | 021-23183969 | yanglin2@gtht.com | S0880525040027 | | 杨蒙(分析师) | 021-23185700 | yangmeng@gtht.com | S0880525040072 | 本报告导读： AI 业务推动公司向产品型、数智解决方案供应商逐步转型，AI 生态圈不断扩大，看 好公司在 AI 时代的发展潜力。 | 52 周内股价区间(元) | 11.15-25.22 | | --- | --- | | 总市值(百万元) | 18,973 | | 总股本/流通A股(百万股) | 1,022/977 | | 流通 B 股/H 股(百万股) | 0/0 | [Table_Balance] 资产负债表摘要(LF) | 股东权益(百万元) | 5,508 | | --- | --- | | 每股净资产(元) | 5.39 | | 市净率( ...

Investment Rating - The investment rating for the company is "Accumulate" [2][4]. Core Views - The report indicates a significant decline in net profit attributable to the parent company, which decreased by 36.9% year-on-year for Q1 to Q3 of 2025. The company is actively seeking investment opportunities in new productive forces and hard technology sectors to secure long-term returns [3][4]. - The company has initiated the construction of the AIAgent platform for the construction industry, aiming to provide intelligent solutions for the entire architectural design process [3][6]. Financial Performance Summary - For Q1 to Q3 of 2025, the company's revenue reached 889 million yuan, reflecting a year-on-year growth of 10.1%. However, the net profit attributable to the parent company was 70 million yuan, down 36.9% year-on-year [4]. - The gross profit margin decreased by 3.1 percentage points to 25.9%, while the net profit margin fell by 5.9 percentage points to 7.9% [4]. - The company has adjusted its earnings per share (EPS) forecasts for 2025-2027 to 0.54, 0.61, and 0.64 yuan, representing changes of -15.2%, 12.6%, and 4.7% respectively [4][7]. Investment Opportunities - The company is focusing on expanding its international business along the "Belt and Road" initiative while consolidating its domestic market presence [5]. - It has made investments in Shenzhen's Zhongtou Xinyao No.1 Technology Investment Partnership to leverage resources and advantages in equity investment for long-term returns [5]. Digital Transformation Initiatives - The company is advancing its digital transformation by exploring data value and applying artificial intelligence in architectural design and engineering cost consulting [6]. - The AIAgent platform, which integrates large model technology, aims to reshape the architectural design process and provide intelligent solutions throughout the design workflow [6].

Investment Rating - The report assigns an "Accumulate" rating for the industry, indicating a positive outlook for investment opportunities in the new tobacco sector [4]. Core Insights - The new tobacco business of British American Tobacco is expected to accelerate growth in the second half of 2025, benefiting from a favorable industry environment [2]. - The global HNB (Heated Not Burned) industry is entering a new product lifecycle, with major brands actively engaging in market cultivation, leading to accelerated industry expansion [4]. - The Glo brand's market share is projected to stabilize and recover in 2026, primarily driven by the Glo Hilo product [4]. Summary by Sections HNB Market Performance - The Glo Hilo product has received positive feedback, with a market share of 1% in Japan and faster acquisition of market share in Poland and Italy [4]. - The overall revenue growth for 2025 is expected to be steady, influenced by competitive activities and resource reallocation [4]. E-Cigarette and New Products - The vaping market is benefiting from an improved market environment, with the Vuse brand gaining a 0.1 percentage point increase in market share, particularly in the U.S. where it rose by 0.7 percentage points [4]. - The Velo Plus product is driving significant growth in the U.S. market, achieving a 9.2 percentage point increase in market share to 15.6% [4]. Traditional Cigarette Business - The traditional cigarette business remains stable, with a slight decline in market share of 0.1 percentage points globally, but a 0.2 percentage point increase in the U.S. [4]. - The company anticipates a revenue growth of approximately 2% for the fiscal year 2025, with new tobacco revenue accelerating and expected to achieve double-digit growth in the second half of 2025 [4].

稳中求进，修炼内功 [Table_Authors] 刘姜枫(分析师) 政策基调总体温和，下调对外风险评价，重视短期的扩大内需和中长期的"内功" 修炼。 投资要点： | 021-38031032 | | --- | | liujiangfeng@gtht.com | | | 邵睿思(研究助理) | | --- | --- | | | 010-83939827 | | | shaoruisi@gtht.com | | 登记编号 | S0880125070011 | | | 梁中华(分析师) | | | 021-23219820 | | | liangzhonghua@gtht.com | | 登记编号 | S0880525040019 | [Table_Report] 相关报告 核心 CPI 同比维持高位 2025.12.10 出口：动能修复，但基数将升 2025.12.08 内需主导，提质增效 2025.12.08 美联储降息：或踩刹车 2025.11.21 收入增速升，支出需加码 2025.11.17 券 研 究 报 告 请务必阅读正文之后的免责条款部分 宏 ——2025 年 12 月中央经济工作会议学习体会 ...

Investment Rating - The report assigns an "Overweight" rating for the industry [1]. Core Viewpoints - The electricity demand continues to rise, with a long-term positive outlook for thermal power [2]. Summary by Sections - The report highlights improvements in photovoltaic pricing mechanisms, with specific prices for various regions: 1. Fujian offshore photovoltaic/other renewable energy prices are 0.388/0.350 CNY/kWh 2. Ningxia unified price is 0.2595 CNY/kWh (upper limit clearing) 3. Hebei southern network wind/photovoltaic prices are 0.353/0.3344 CNY/kWh 4. Jibei wind/photovoltaic prices are 0.347/0.352 CNY/kWh 5. Liaoning's 2026 wind mechanism price is 0.33 CNY/kWh, photovoltaic 0.3 CNY/kWh 6. Shaanxi photovoltaic mechanism price is 0.350 CNY/kWh, wind mechanism price is 0.352 CNY/kWh These prices show a significant improvement compared to previous levels around 0.2 CNY [4]. - The report notes that the user-side energy storage price difference is diminishing, reflecting government judgments on price differences. In December, the peak-valley price difference exceeded 0.6 CNY/kWh in 20 regions, with Shanghai reaching a high of 1.6 CNY/kWh (MOM +30%) and Zhejiang at 1.4 CNY/kWh (MOM +33%) [4]. - The report discusses the electricity supply situation in Heilongjiang, predicting a tight balance to a shortfall during peak summer and winter months. The maximum load in December is expected to reach 19.7 million kW (YOY +11%), with a maximum power shortfall of 570,000 to 860,000 kW [4].

Investment Rating - The report assigns an "Overweight" rating for the banking sector [7]. Core Insights - The report emphasizes the significant improvement in the cost of liabilities for banks in 2025, with a notable decrease of 28 basis points (bp) in the first half of the year, compared to only 4 bp in the same period last year. This improvement is primarily driven by reductions in deposit and interbank liabilities costs, contributing 19 bp and 7 bp respectively [3][11]. - The net interest margin (NIM) is expected to decline by approximately 5 bp in 2026, with the downward pressure on margins continuing to ease marginally, suggesting that some banks may stabilize their NIMs [2][10]. Summary by Sections 1. Liability Cost Improvement in 2025 - The first half of 2025 saw a significant reduction in the cost of interest-bearing liabilities, with the cost rate dropping to 1.70%, a decrease of 28 bp from 2024. This was supported by improvements in both deposit and interbank liability costs [11]. 2. Liability Side: Deposit Maturity and Repricing Benefits 1) **Term Structure**: The proportion of long-term deposits entering the repricing cycle has increased, with the share of deposits with a remaining maturity of 1-5 years declining by 1.5 percentage points (pct) to 22.6% by the end of Q2 2025. Some banks, such as those in Ningbo and Chongqing, experienced declines exceeding 10 pct [4]. 2) **Price Factors**: Regulatory focus on maintaining reasonable NIM levels has increased, with expectations of further interest rate cuts. The maximum reduction for three-year deposits could exceed 100 bp, indicating substantial room for cost improvement [5]. 3. Asset Side: Yield Pressure Expected to be Better than 2025 1) **Loans**: The repricing pressure on loans is expected to ease, with the five-year Loan Prime Rate (LPR) declining by only 10 bp in 2025, significantly less than the 50 bp drop the previous year [6]. 2) **Debt Replacement**: The shift from high-interest to low-interest debt is anticipated to have a limited impact on net interest margins, estimated to drag down margins by about 4 bp [6]. 3) **Bond Maturity**: The widening gap between new bond issuance rates and existing bond yields is expected to exert downward pressure on investment yields, with an estimated drag of 6 bp on margins from the reallocation of bonds maturing within one year [6]. 4. NIM Projections - The report forecasts a 5 bp decline in NIM for 2026, with the downward trend continuing to converge. The asset yield is expected to decrease by 17 bp, while the cost of liabilities is projected to improve by 13 bp, with deposit costs improving by 17 bp [7][10].

Investment Rating - The report maintains an "Accumulate" rating for China Pacific Insurance (2328) [8] Core Views - The report suggests that short-term personnel changes will not affect the long-term operational stability of the company, with a positive outlook on the clear strategic planning for both auto and non-auto insurance, which is expected to drive continuous improvement in underwriting profitability [3][12] - The report forecasts EPS for 2025-2027 to be 2.14, 2.40, and 2.55 RMB respectively, with a target price of 22.82 HKD for 2025 [12] Financial Summary - **Insurance Service Revenue (Million RMB)**: - 2023A: 457,203 - 2024A: 485,223 (+6%) - 2025E: 507,552 (+5%) - 2026E: 532,082 (+5%) - 2027E: 559,006 (+5%) [6] - **Net Profit (Attributable to Parent) (Million RMB)**: - 2023A: 24,585 - 2024A: 32,173 (+30.9%) - 2025E: 47,582 (+47.9%) - 2026E: 53,294 (+12.0%) - 2027E: 56,609 (+6.2%) [6] - **Price-to-Earnings (PE) Ratio**: - 2023A: 13.97 - 2024A: 10.67 - 2025E: 7.22 - 2026E: 6.44 - 2027E: 6.07 [6] - **Price-to-Book (PB) Ratio**: - 2023A: 1.48 - 2024A: 1.33 - 2025E: 1.19 - 2026E: 1.05 - 2027E: 0.94 [6] Strategic Insights - The company is expected to maintain stable operations in its core business despite recent personnel changes, with the appointment of Zhang Daoming as the interim head, who has 27 years of management experience in the insurance industry [12] - The report highlights a clear strategic plan that is expected to enhance both premium income and profitability in the long term, particularly through the optimization of the auto insurance cost structure and the governance of non-auto insurance [12] - The company is actively responding to national policies to develop overseas business models, focusing on serving "Chinese enterprises" and "Chinese products," with significant progress in underwriting key projects along the Belt and Road Initiative [12]

宏 观 研 究 美联储如期降息，开启技术性扩表 [Table_Authors] 汪浩(分析师) ——2025 年 12 月美联储议息会议点评 本报告导读： 2025 年 12 月美联储降息 25BP，基本符合预期，但是内部分歧加大，表态上后续降 息更为谨慎，同时开启准备金管理购买的技术性扩表。在劳动力市场结构性变化和 美联储主席换届的背景下，我们预计 2026 年可能还有 2-3 次降息，美债利率先下后 上，美股仍有进一步支撑。 投资要点： 宏观研究 /[Table_Date] 2025.12.11 | | 0755-23976659 | | --- | --- | | | wanghao8@gtht.com | | 登记编号 | S0880521120002 | | | 梁中华(分析师) | | | 021-23219820 | | | liangzhonghua@gtht.com | | 登记编号 | S0880525040019 | [Table_Report] 相关报告 通胀能否回升 2025.12.01 外需修复，推升供给 2025.11.30 同比转负，有待需求提振 2025.11.27 弱就业、 ...

Investment Rating - The report maintains an "Overweight" rating for the industry [1][5]. Core Insights - The medical device procurement scale continues to grow, driven by ongoing equipment update policies, which are expected to lead to a long-term increase in procurement levels. The report recommends medical device companies that are likely to benefit from these policies, including Mindray Medical, United Imaging, Kaili Medical, and Aohua Endoscopy [3][5]. - In November 2025, the new equipment procurement scale showed significant year-on-year growth: MRI increased by 11.1%, CT by 26.4%, DR by 47.2%, ultrasound by 17.0%, while endoscopes declined by 4.9%, and surgical robots grew by 8.6%. Cumulatively, from January to November 2025, MRI grew by 50.4%, CT by 72.7%, DR by 74.0%, ultrasound by 56.1%, endoscopes by 19.7%, and surgical robots by 32.8% [5]. - The equipment update policy is expected to drive procurement levels significantly, with a target of over 25% growth in medical equipment investment by 2027 compared to 2023. This policy is expected to enhance the configuration of high-end equipment to levels comparable to middle-income countries [5]. - The domestic market is showing signs of recovery, with a notable increase in procurement demand from medical institutions, reflecting a positive trend in the medical equipment industry. For instance, United Imaging reported a revenue of 6.866 billion yuan in the domestic market for the first three quarters of 2025, representing a year-on-year growth of 23.7% [5]. Summary by Sections - **Investment Recommendations**: The report suggests maintaining an "Overweight" rating and recommends companies likely to benefit from the equipment update policies [5]. - **Market Trends**: The report highlights the growth in procurement scale for various medical devices, indicating a robust market environment [5]. - **Policy Impact**: The ongoing implementation of equipment update policies is expected to significantly enhance procurement levels in the medical sector [5].